Clinical Trial

Augmented Reality as Discharge Information for Hospitalized Cardiology Patients

Study acronym: RACAR
Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information. This study includes adult patients who are admitted to a cardiology department because of: * Ischaemic heart disease * Atrial fibrillation * Heart failure * Or who need a pacemaker implantation The main questions this study aims to answer are: * Does providing augmented reality information at discharge improve patients' perceived quality of care? * Does it improve patients' adherence to their prescribed treatment? * Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death? Researchers will compare two groups of participants: * A control group, who will receive the usual medical discharge report. * An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application. Participants will: * Receive their discharge information according to the group they are assigned to. * Use the augmented reality application if they are in the intervention group. * Be followed over time to assess treatment adherence, patient experience, and cardiovascular events. This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.
Trial Details
NCT Number NCT07399379
Lead Sponsor Hospital Universitario Getafe
Conditions Myocardial Infarction (MI), Pacemaker Implantation, Heart Failure, Atrial Fibrillation (AF)
Enrollment 303 participants
Start Date 2024-02-23
Primary Completion 2025-12-16 (estimated)
Study Completion 2025-12-29 (estimated)
Updated on ClinicalTrials.gov 2026-02-10